ARYLQUINOLINE, ARYLQUINOLONE AND ARYLTHIOQUINOLONE DERIVATIVES AND USE THEREOF TO TREAT CANCER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160332971A1
SERIAL NO

15152185

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Arylquinoline derivatives and their use for treating cancer or cancer metastasis is disclosed. The compounds of the subject technology promote cells to secrete a pro-apoptotic tumor suppressor, i.e., prostate apoptosis response-4 (Par-4), which in turn promote apoptosis in cancer cells or metastatic cells.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION201 GILLIS BUILDING LEXINGTON KY 40506-0033

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BURIKHANOV, Ravshan Lexington, US 5 5
LIU, Chunming Lexington, US 39 239
RANGNEKAR, Vivek M Lexington, US 7 8
SVIRIPA, Vitaliy M Lexington, US 8 12
WATT, David S Lexington, US 15 12
ZHANG, Wen Lexington, US 358 1612

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation